VI
ASTH icon

Versor Investments’s Astrana Health ASTH Stock Holding History

Versor Investments’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-8,211
Closed -$253K – 886
2023
Q3 		$253K Buy
+8,211
New +$283K 0.05% 529
2022
Q4 		– Sell
-13,403
Closed -$523K – 1017
2022
Q3 		$523K Sell
13,403
-6,997
-34% -$320K 0.03% 432
2022
Q2 		$787K Buy
+20,400
New +$776K 0.03% 333

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Versor Investments's ASTH Position: Q4 2023 in Review

Versor Investments sold out of Astrana Health (ASTH) in Q4 2023, closing a stake of 8,211 shares — an estimated $253K sold.

Versor Investments first reported a position in ASTH in Q2 2022 and held it in 3 quarters. The position peaked at $787K in Q2 2022. 143 funds tracked by Wall St. Rank hold ASTH as of Q4 2023.

  • Versor Investments reported no remaining Astrana Health position as of Q4 2023 after selling out during the quarter.
  • Versor Investments sold 8,211 Astrana Health shares in Q4 2023, an estimated $253K.
  • Versor Investments first reported a position in Astrana Health in Q2 2022 and held it in 3 quarters.
  • Versor Investments's Astrana Health position peaked at $787K in Q2 2022.
  • 143 funds tracked by Wall St. Rank held Astrana Health as of Q4 2023.

Based on Versor Investments's 13F filing for Q4 2023, filed 7 Feb 2024.